Skip to main content
رجوع
QGEN logo

Qiagen N.V.

جودة البيانات: 100%
ذروة بيع
QGEN
NYSE Healthcare Medical - Diagnostics & Research
KWD 39.78
▲ KWD 0.29 (0.73%)
القيمة السوقية: 8.20B
نطاق اليوم
KWD 39.24 KWD 40.04
نطاق 52 أسبوعًا
KWD 38.13 KWD 57.82
حجم التداول
1,580,735
متوسط 50 يوم / 200 يوم
KWD 48.45 / KWD 47.37
الإغلاق السابق
KWD 39.49

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (627 نظير)

المقياس السهم وسيط القطاع
P/E 19.3 0.3
P/B 2.2 2.9
ROE % 11.6 3.7
Net Margin % 20.3 3.8
Rev Growth 5Y % -1.9 10.0
D/E 0.4 0.2

السعر المستهدف للمحللين

Hold
KWD 54.330 +36.6%
Low: KWD 50.000 High: KWD 59.000
مكرر الربحية المستقبلي
15.7
ربحية السهم المستقبلية
KWD 2.516
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
2.2 B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 3.538
KWD 3.512 – KWD 3.591
2.8 B 2
FY2029 KWD 3.275
KWD 3.250 – KWD 3.323
2.6 B 2
FY2028 KWD 3.021
KWD 2.735 – KWD 3.661
2.5 B 4

النقاط الرئيسية

Revenue declined -1.85% annually over 5 years
Earnings grew 408.28% over the past year
ROE of 11.57% — decent returns on equity
Net margin of 20.33% shows strong profitability
Debt/Equity of 0.44 — conservative balance sheet
Generating 453.28M in free cash flow

النمو

Revenue Growth (5Y)
-1.85%
Revenue (1Y)5.65%
Earnings (1Y)408.28%
FCF Growth (3Y)23.61%

الجودة

Return on Equity
11.57%
ROIC7.18%
Net Margin20.33%
Op. Margin24.90%

الأمان

Debt / Equity
0.44
Current Ratio3.90
Interest Coverage15.65

التقييم

P/E Ratio
19.29
P/B Ratio2.17
EV/EBITDA17.32
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 5.65% Revenue Growth (3Y) 3.12%
Earnings Growth (1Y) 408.28% Earnings Growth (3Y) 11.57%
Revenue Growth (5Y) -1.85% Earnings Growth (5Y) -4.58%
Profitability
Revenue (TTM) 2.09B Net Income (TTM) 424.88M
ROE 11.57% ROA 6.75%
Gross Margin 61.79% Operating Margin 24.90%
Net Margin 20.33% Free Cash Flow (TTM) 453.28M
ROIC 7.18% FCF Growth (3Y) 23.61%
Safety
Debt / Equity 0.44 Current Ratio 3.90
Interest Coverage 15.65 Dividend Yield 0.01%
Valuation
P/E Ratio 19.29 P/B Ratio 2.17
P/S Ratio 3.92 PEG Ratio 0.05
EV/EBITDA 17.32 Dividend Yield 0.01%
Market Cap 8.20B Enterprise Value 9.01B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2.09B 1.98B 1.97B 2.14B 2.25B
Net Income 424.88M 83.59M 341.30M 423.21M 512.60M
EPS (Diluted) 2.04 0.38 1.65 2.05 2.47
Gross Profit 1.29B 967.35M 1.23B 1.38B 1.45B
Operating Income 520.31M 97.71M 409.94M 531.46M 630.08M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6.30B 5.69B 6.12B 6.29B 6.15B
Total Liabilities 2.52B 2.12B 2.31B 2.82B 3.05B
Shareholders' Equity 3.78B 3.57B 3.81B 3.47B 3.10B
Total Debt 1.65B 1.61B 1.69B 2.03B 2.12B
Cash & Equivalents 839.01M 663.56M 668.08M 730.67M 880.52M
Current Assets 2.00B 1.96B 2.15B 2.39B 2.11B
Current Liabilities 512.14M 543.63M 1.08B 974.52M 1.52B

درجات الاستراتيجيات

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
#930 of 1052
24

النشاط الأخير

دخل Cash Flow Compounder
Mar 24, 2026